Taking cholesterol-lowering drugs like statins really does lower cholesterol in Japanese people with high cholesterol, just like it does in others.

What we've found so far is that the evidence we've reviewed supports the idea that HMG-CoA reductase inhibitors, commonly known as statins, are linked to lower total cholesterol in Japanese patients with hyperlipidemia [1]. Our analysis of the available research shows no studies that refute this link. We analyzed 42.0 studies or assertions, all of which support the effect of these drugs on lowering cholesterol in this group [1]. The evidence we've reviewed leans toward the conclusion that statins reduce total cholesterol levels in Japanese individuals with high cholesterol, similar to what has been observed in other populations [1]. It’s important to note that while the direction of the evidence is consistent, our current analysis does not allow us to say how much cholesterol is lowered, how quickly, or whether all statins have the same effect. We are also not able to assess long-term outcomes or side effects from the data provided. Since all the assertions we reviewed support this effect and none contradict it, the balance of evidence we’ve seen so far points in one direction—but that doesn’t mean the picture is complete. We don’t yet know if there are subgroups of Japanese patients with hyperlipidemia for whom the effect might differ, or how factors like diet, genetics, or dosage might influence the outcome. Our understanding is based on the data available to us now, and future evidence could refine or expand what we know. Practical takeaway: If you're a Japanese patient with high cholesterol, the existing evidence we’ve reviewed suggests statins are associated with lower total cholesterol levels. But always talk to your doctor about your specific health situation.